BIOMARKERS
Biomarkers for Bone cancer
1. BCR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. ER
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. NR4A3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. PSA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. ABL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. TP53
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. PR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. ESR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. YWHAE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. ERBB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. BCL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. MYC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. AKT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. MS4A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. FBXW7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. MAPK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. KIT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. AR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. IL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. CDKN2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. EWSR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. PTPRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. CEACAM5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. CALCB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. Ki-67
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. CXCR4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. FANCA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. LDH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. FUS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. EGFR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. TG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. SRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. PIK3CA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. DDIT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. CTLA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. TIMP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. JUN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. CD79A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. JAK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. MUC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. APC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. BRD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. PPFIBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. FAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. MTOR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. RB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. KMT2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. FLT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. SDHB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. ITK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. FH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. IGH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. RUNX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. KDR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. FGFR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. STAT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. BLM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. MDM2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. FLI1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. ROS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. GNAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. MAX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. MYCN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. PTPN11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. SPEN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. HLA-A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. PTCH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. ENO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. PTEN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. TP63
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. BRCA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. ETV6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ALK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. SMAD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. PML
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. SMAD3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. HIF1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. NTRK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. MPL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. AFP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. KRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. HRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. PDGFRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. BRCA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. NF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. SERPINE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. ARID1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. RARA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. POU5F1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. ERG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. NRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. SMAD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. CALR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. CDK4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. ATM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. POLE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. BRAF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. RHOA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. CCDC6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. CDC73
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. PRKAR1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. hCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. FANCD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. NPM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. WT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. SMARCB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. IDH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. MET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. EXT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. TERT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. uPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. ABCG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. ABL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. BMPR1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. NCKIPSD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. STAT5B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. FANCC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. CCND1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. CDKN1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. CREBBP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. NF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. MUC16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. ELN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. CYLD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. RET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. HSP90AA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. CUX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. CDH11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. TFRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. GATA3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. IDH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. PRF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. PDGFRA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. VHL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. FOXP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. MYB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. FLT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. GOPC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. NOTCH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. STIL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. FGFR3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. SDHA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. PAX5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. MYD88
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. PDGFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. SOX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. PDCD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. RECQL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. EZH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. TET2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. RAC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. RHOH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. ACVR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. FOXO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. MECOM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. IL6ST
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. MAP2K1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. NBN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. ASXL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. CBL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. CDK6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. JAK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. ATR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. CD52
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. BTK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SMO
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. TAL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. LMNA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. MDM4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. MYH11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. BCL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. EP300
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. RAF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. EXT2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. SSX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. TCF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. CgA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. MEN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. NUTM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. CEBPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. HOXA9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. IKZF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. MYOD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. HMGA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. MLH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. NUP98
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. SS18
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. TSC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. ERBB3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. FANCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. CLIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. FES
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. PAX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. CD274
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. ERCC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. MLLT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. Beta-hCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. CBFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. NKX2-1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. ZNF198
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. PBX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. SDHD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. SYK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. MAF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. COL1A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. COL2A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. FEV
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. NT5C2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. STK11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. CDH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. USP6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. CDX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. FIP1L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. SALL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. REL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. SF3B1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. BRIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. PIM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. SBDS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. IRF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. MLLT10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. TCL1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. WHSC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. CDKN2C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. DNMT3A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. KLF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. MSH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. TNFRSF17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. TRIM27
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. BCOR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. CIC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. CTNNB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. RPL22
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. TSC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. ETV5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. GATA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. GATA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. HOXD13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. NDRG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. NOTCH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. STAT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. TFE3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. Neurokinin
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. CCND2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. CHEK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. ETV4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. FOXO3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. HEY1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. MLLT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. PCSK7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. SSX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. XPO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. B2M
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. CD79B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. EBF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. NFE2L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. NSD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. SMARCA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. SOCS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. U2AF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. BIRC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. CASP8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. FHIT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. LCK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. MALT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. MITF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. PAX7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. PHOX2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. SDHC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. AKT2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. ATF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. BCL10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. ELF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. ETV1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. IL7R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. PICALM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. PRDM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. TGFBR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. AXIN2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. DUX4L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. ERCC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. TNFAIP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. WRN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. CD74
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. DICER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. ERBB4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. FANCF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. FGFR1OP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. FGFR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. FUBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. HERPUD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. JAK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. KLK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. LEF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. LMO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. ZBTB16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. CYP2D6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. CRTC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. CSF3R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. IGL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. RUNX1T1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. SETBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. SRSF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. TMPRSS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. WAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. ACVR2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. BCL11A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. CANT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. CBFA2T3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. DEK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. ELL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. AXIN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. BCL9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. CARS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. CCND3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. FCGR2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. H3F3A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. MAFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. MALAT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. MLLT11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. MSH6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. NAB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. NCOA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. PALB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. SND1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. TLX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. XPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. CREB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. EML4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. ERCC5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. FANCE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. FOXP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. IGK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. MAP2K4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. PAX8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. PLCG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. PRCC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. PRDM16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. TAF15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. TET1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. TRA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. XPC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. TOP2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. AMER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. ARID1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. ATRX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. DDX5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. FGFR4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. MN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. NCOR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. NFATC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. NUP214
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. WIF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. BAP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. CREB3L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. HLF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. KLF6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. MAP3K1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. MNX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. NCOR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. NFIB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. NRG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. NTRK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. PDCD1LG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. POT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. RPL5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. SH2B3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. SUZ12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. TCF12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. TLX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. ZNF331
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. HER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. BCL11B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. CARD11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. CCNE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. CIITA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. CTCF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. DROSHA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. GPC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. H3F3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. MAML2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. MUTYH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. PBRM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. PLAG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. PMS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. PPARG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. PPM1D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. SEPT9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. SETD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. SFPQ
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. SUFU
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. TCF7L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. TFEB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. TOP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. ALDH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. ARNT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. BCL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. BRD3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. CAMTA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. CNTRL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. ERCC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. FOXA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. GMPS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. LIFR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. LMO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. MKL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. MSN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. NFKB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. OLIG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. PTPN13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. RANBP2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. RBM15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. SFRP4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. SPECC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. STAG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. TNFRSF14
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. TPR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. UBR5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. WWTR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. AFF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. BCORL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. BTG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. CHIC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. CREB3L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. DDR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. DDX10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. DNAJB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. FAT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. FLCN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. FOXO4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. GNAQ
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. KDM6A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. KEAP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. LPP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. MAP2K2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. MLF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. MTCP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. MYH9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. NONO
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. OMD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. PMS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. RAD21
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. RALGDS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. SSX4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. TFG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. TMEM127
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. TSHR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. ZRSR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. WFDC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. ASPSCR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. BCL9L
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. BUB1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. CACNA1D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. CASC5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. CHD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. DAXX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. DDX3X
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. EPS15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. EZR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. GNA11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. GRIN2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. HIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. HIST1H3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. HMGA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. HNF1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. HOXC13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. HOXD11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. JAZF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. KAT6A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. KAT6B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. KIAA1549
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. KMT2C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. KTN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. LCP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. LYL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. PTK6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. PTPRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. RPL10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. RPN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. SDHAF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. SETP5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. SLC45A3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. SMARCD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. SMARCE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. TBX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. THRAP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. TRD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. CEP17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. PAM50
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. ACSL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. ACSL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. AKAP9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. APOBEC3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. ARHGAP26
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. ARHGEF12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. ARID2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. CBLC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. CDK12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. CNBP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. CRLF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. DDB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. DDX6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. DNM2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. EIF4A2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. EPAS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. ETNK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. FOXL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. FSTL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. GAS7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. HOXA13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. HOXC11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. HSP90AB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. IL21R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. KCNJ5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. KDM5C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. KIF5B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. KMT2D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. LASP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. LRIG3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. LRP1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. MDS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. MED12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. MLLT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. MYCL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. NCOA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. NCOA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. NFKBIE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. NUMA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. NUTM2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. PCM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. PER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. PHF6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. PIK3R1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. POU2AF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. PRRX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. PTPRK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. RABEP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. RMI2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. RNF43
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. RSPO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. SDC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. STRN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. TBL1XR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. TPM3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. TPM4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. USP8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. ZNF384
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. IHC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. SET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. ABI1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. ACKR3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. AFF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. AFF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. ATIC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. ATP1A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. ATP2B3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. BCL5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. BCL7A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. C12orf9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. C15orf65
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. C2orf44
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. CBLB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. CCNB1IP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. CEP89
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. CHCHD7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. CLP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. CLTC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. CLTCL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. CNOT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. COX6C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. CRTC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. DCTN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. ECT2L
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. EIF3E
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. ELK4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. ERC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. FAM131B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. FAM46C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. FAT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. FBXO11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. FCRL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. FNBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. GOLGA5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. GPHN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. HIST1H4I
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. HMGN2P46
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. HNRNPA2B1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. HOOK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. HOXA11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. IKBKB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. KDM5A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. KDSR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. KIAA1598
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. LHFP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. LSM14A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. LZTR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. MAP3K13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. MLLT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. MSI2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. MYO5A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. NACA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. NIN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. NUTM2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. P2RY8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. PAFAH1B2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. PDE4DIP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. PPP2R1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. PPP6C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. PREX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. PRKACA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. PSIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. PTPRT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. PWWP2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. QKI
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. RAD51B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. RANBP17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. RAP1GDS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. RBM10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. RNF213
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. RNF217-AS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. RSPO3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. RUNDC2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. SEPT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. SH3GL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. SLC34A2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. SPOP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. SRGAP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. SRSF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. SS18L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. TAL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. TCEA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. TCL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. TFPT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. TRAF7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. TRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. TRIM24
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. TRIM33
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. TRIP11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. TRRAP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. TTL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. VTI1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. WHSC1L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. ZCCHC8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. ZFHX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. ZNF278
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. ZNF521
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. Cytokeratin fragment 21-1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. MAP-Tau mRNA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. MK167
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. Nuclear matrix protein 22
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CAD-ALK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]